Complex Perianal Fistula Clinical Trial
Official title:
Phase II Study to Evaluate Efficacy and Safety of ANTG-ASC (Autologous Cultured Adipose-derived Stem Cells) on the Complex Fistula Patients
Mesenchymal stem cells derived from adipose tissue are pluripotent to differentiate into myocytes, adipocytes or others. They have an immunosuppressive activity. Complex perianal fistula is difficult to cure and easy to relapse. Autologous adipose stem cells have shown efficacy and safety on Crohn's fistula in phase 1 study. Based on these results, the investigators would apply autologous adipose stem cells on complex perianal fistula to evaluate their efficacy and safety.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01020825 -
Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial
|
||
| Completed |
NCT04075825 -
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
|
Phase 3 | |
| Recruiting |
NCT04701411 -
A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's Disease
|
Phase 3 | |
| Active, not recruiting |
NCT04118088 -
A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula
|
Phase 4 | |
| Terminated |
NCT01378390 -
Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease
|
Phase 3 | |
| Active, not recruiting |
NCT04940611 -
A Study of Surgical Interventions in Fistulizing Conditions
|
||
| Active, not recruiting |
NCT04971525 -
A Study to Check How Often People Treated With Darvadstrocel for Crohn's Disease Are Diagnosed With Cancer
|